> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Hims & Hers Super Bowl Ad Hit
- URL: https://www.fdaweb.com/hims-hers-super-bowl-ad-hit/
- Published: 2026-03-10T12:00:00.000Z
- Updated: 2026-09-14T13:35:09.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5160793

The Institute for Safe Medicines says FDA, the Federal Trade Commission, and the Department of Justice should take immediate action against Hims & Hers for its Super Bowl ad that promoted unapproved compounded drug products. A 3/3 [letter](ttps://www.safemedicines.org/wp-content/uploads/2026/03/FDA-HIMS-letter-1.pdf) to FDA says the ad “contained a startling array of unsubstantiated and misleading claims.”

The letter says Hims & Hers is a repeat violator, noting that as recently as 9/9/2025, FDA issued two Warning Letters to the company for false or misleading promotion of compounded drug products.

“FDA and the Federal Trade Commission should take immediate enforcement to protect the public health and respond to this brazen conduct,” the institute writes. “The Department of Justice should consider action such as seeking an injunction, product seizure, prosecutions, and civil and criminal penalties….”